These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 29456529

  • 1. Challenges and Opportunities for Biomarkers of Clinical Response to AHSCT in Autoimmunity.
    Harris KM, Lu T, Lim N, Turka LA.
    Front Immunol; 2018; 9():100. PubMed ID: 29456529
    [Abstract] [Full Text] [Related]

  • 2. The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive Therapies.
    Amoriello R, Greiff V, Aldinucci A, Bonechi E, Carnasciali A, Peruzzi B, Repice AM, Mariottini A, Saccardi R, Mazzanti B, Massacesi L, Ballerini C.
    Front Immunol; 2020; 11():559. PubMed ID: 32328061
    [Abstract] [Full Text] [Related]

  • 3. Immunological correlates of favorable long-term clinical outcome in multiple sclerosis patients after autologous hematopoietic stem cell transplantation.
    Arruda LCM, de Azevedo JTC, de Oliveira GLV, Scortegagna GT, Rodrigues ES, Palma PVB, Brum DG, Guerreiro CT, Marques VD, Barreira AA, Covas DT, Simões BP, Voltarelli JC, Oliveira MC, Malmegrim KCR.
    Clin Immunol; 2016 Aug; 169():47-57. PubMed ID: 27318116
    [Abstract] [Full Text] [Related]

  • 4. Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
    Darlington PJ, Stopnicki B, Touil T, Doucet JS, Fawaz L, Roberts ME, Boivin MN, Arbour N, Freedman MS, Atkins HL, Bar-Or A.
    Front Immunol; 2018 Aug; 9():834. PubMed ID: 29867923
    [Abstract] [Full Text] [Related]

  • 5. Extensive intrathecal T cell renewal following hematopoietic transplantation for multiple sclerosis.
    Harris KM, Lim N, Lindau P, Robins H, Griffith LM, Nash RA, Turka LA, Muraro PA.
    JCI Insight; 2020 Jan 30; 5(2):. PubMed ID: 31877116
    [Abstract] [Full Text] [Related]

  • 6. Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
    Casanova B, Jarque I, Gascón F, Hernández-Boluda JC, Pérez-Miralles F, de la Rubia J, Alcalá C, Sanz J, Mallada J, Cervelló A, Navarré A, Carcelén-Gadea M, Boscá I, Gil-Perotin S, Solano C, Sanz MA, Coret F.
    Neurol Sci; 2017 Jul 30; 38(7):1213-1221. PubMed ID: 28396953
    [Abstract] [Full Text] [Related]

  • 7. Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients.
    Vaivade A, Wiberg A, Khoonsari PE, Carlsson H, Herman S, Al-Grety A, Freyhult E, Olsson-Strömberg U, Burman J, Kultima K.
    Lipids Health Dis; 2023 Jul 07; 22(1):97. PubMed ID: 37420217
    [Abstract] [Full Text] [Related]

  • 8. Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
    Moore JJ, Massey JC, Ford CD, Khoo ML, Zaunders JJ, Hendrawan K, Barnett Y, Barnett MH, Kyle KA, Zivadinov R, Ma KC, Milliken ST, Sutton IJ, Ma DDF.
    J Neurol Neurosurg Psychiatry; 2019 May 07; 90(5):514-521. PubMed ID: 30538138
    [Abstract] [Full Text] [Related]

  • 9. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ, Cai QC, Shi YX, Lin XB, Wei J, Guo Y, Pan ZH.
    Ai Zheng; 2006 Aug 07; 25(8):1023-8. PubMed ID: 16965687
    [Abstract] [Full Text] [Related]

  • 10. Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers.
    Malmegrim KCR, Lima-Júnior JR, Arruda LCM, de Azevedo JTC, de Oliveira GLV, Oliveira MC.
    Front Immunol; 2018 Aug 07; 9():2602. PubMed ID: 30505303
    [Abstract] [Full Text] [Related]

  • 11. Resetting the immune response after autologous hematopoietic stem cell transplantation for autoimmune diseases.
    Arruda LC, Clave E, Moins-Teisserenc H, Douay C, Farge D, Toubert A.
    Curr Res Transl Med; 2016 Aug 07; 64(2):107-13. PubMed ID: 27316394
    [Abstract] [Full Text] [Related]

  • 12. Progress and prospects for the use and the understanding of the mode of action of autologous hematopoietic stem cell transplantation in the treatment of multiple sclerosis.
    Collins F, Kazmi M, Muraro PA.
    Expert Rev Clin Immunol; 2017 Jun 07; 13(6):611-622. PubMed ID: 28277827
    [Abstract] [Full Text] [Related]

  • 13. Autologous hematopoietic stem cell transplantation in combination with immunoablative protocol in secondary progressive multiple sclerosis--A 10-year follow-up of the first transplanted patient.
    Obradović D, Tukić L, Radovinović-Tasić S, Petrović B, Elez M, Ostojić G, Balint B.
    Vojnosanit Pregl; 2016 May 07; 73(5):504-8. PubMed ID: 27430119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report.
    Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Griffith LM, Muraro PA, Openshaw H, Sayre PH, Stüve O, Arnold DL, Spychala ME, McConville KC, Harris KM, Phippard D, Georges GE, Wundes A, Kraft GH, Bowen JD.
    JAMA Neurol; 2015 Feb 07; 72(2):159-69. PubMed ID: 25546364
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab.
    Gernert M, Tony HP, Fröhlich M, Schwaneck EC, Schmalzing M.
    Front Immunol; 2021 Feb 07; 12():817893. PubMed ID: 35111167
    [Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of autologous hematopoietic stem-cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis.
    Mariottini A, Innocenti C, Forci B, Magnani E, Mechi C, Barilaro A, Nistri R, Fani A, Saccardi R, Massacesi L, Repice AM.
    Eur J Neurol; 2019 Apr 07; 26(4):624-630. PubMed ID: 30414315
    [Abstract] [Full Text] [Related]

  • 20. NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis.
    Ruder J, Rex J, Obahor S, Docampo MJ, Müller AMS, Schanz U, Jelcic I, Martin R.
    Front Immunol; 2021 Apr 07; 12():794077. PubMed ID: 34975899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.